Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007
The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008
Five years follow-up after pulmonary rehabilitation of patients with COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010
Long-term follow-up of patients with pulmonary sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
1 year clinical follow-up of patients affected by acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005
Systemic inflammatory response during one year follow-up in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Long term pulmonary rehabilitation programs for crhonic obstructive pulmonary disease (COPD). Two years follow-up Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011
Effects of the home-realized 6 months follow-up study individually designed exercise programme on patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 556s Year: 2006
The use of plasmapheresis in the treatment of patients with IY stage of pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
The course of disease of patients who died from asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005
Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
15-year follow-up of patients with cryptogenic fibrosing alveolitis (CFA) Source: Eur Respir J 2002; 20: Suppl. 38, 455s Year: 2002
Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Interstitial lung disease (ILD) in patients with polymyositis/dermatomyositis (PM/DM): clinical features and response to treatment in 6 cases Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001